2012
DOI: 10.1371/journal.pone.0041831
|View full text |Cite
|
Sign up to set email alerts
|

Autophagy Suppresses RIP Kinase-Dependent Necrosis Enabling Survival to mTOR Inhibition

Abstract: mTOR inhibitors are used clinically to treat renal cancer but are not curative. Here we show that autophagy is a resistance mechanism of human renal cell carcinoma (RCC) cell lines to mTOR inhibitors. RCC cell lines have high basal autophagy that is required for survival to mTOR inhibition. In RCC4 cells, inhibition of mTOR with CCI-779 stimulates autophagy and eliminates RIP kinases (RIPKs) and this is blocked by autophagy inhibition, which induces RIPK- and ROS-dependent necroptosis in vitro and suppresses x… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
97
1

Year Published

2013
2013
2018
2018

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 131 publications
(101 citation statements)
references
References 72 publications
3
97
1
Order By: Relevance
“…Consistent with a protective role for autophagy, inhibition of autophagic function with chloroquine can induce cancer cell death through necroptosis. 3 Persistent autophagy can, however, eliminate cancer cells. Enhanced mammary tumorigenesis has been observed in heterozygous Becn1 +/− mice with reduced expression of an essential component required for autophagy.…”
Section: Introductionmentioning
confidence: 99%
“…Consistent with a protective role for autophagy, inhibition of autophagic function with chloroquine can induce cancer cell death through necroptosis. 3 Persistent autophagy can, however, eliminate cancer cells. Enhanced mammary tumorigenesis has been observed in heterozygous Becn1 +/− mice with reduced expression of an essential component required for autophagy.…”
Section: Introductionmentioning
confidence: 99%
“…As discussed above, caspases can actively suppress necroptosis. Autophagy has also been shown to directly inhibit necroptosis by degrading the kinase RIPK1 (Bray et al, 2012). In that study, chemical initiation of autophagy, while inhibiting its completion, led to robust RIPK1-and RIPK3-dependent necroptosis.…”
Section: Interplay Between Autophagy and Other Cell Death Pathwaysmentioning
confidence: 96%
“…In this setting autophagy mitigates ER stress caused by BRAF V600E inhibition, highlighting the additional importance of therapy-induced autophagy as a resistance mechanism (46). Indeed, there are other examples of therapy-induced autophagy functioning as a resistance mechanism, suggesting that augmentation of the anticancer activity of autophagy inhibitor therapeutics may be generally applicable (47)(48)(49)(50).…”
Section: Acknowledgmentsmentioning
confidence: 98%